Artykuły w czasopismach na temat „UPAR”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „UPAR”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Huang, M., Q. Huai, A. Zhou, A. Mazar, G. Parry, A. Kuo, D. Cines, Y. Li, B. Furie i B. C. Furie. "ID: 86 Structural basis of uPAR-uPA and uPAR-vitronectin interactions". Journal of Thrombosis and Haemostasis 4, s1 (październik 2006): 227. http://dx.doi.org/10.1111/j.1538-7836.2006.00086.x.
Pełny tekst źródłaWei, Ying, Ralf-Peter Czekay, Liliane Robillard, Matthias C. Kugler, Feng Zhang, Kevin K. Kim, Jian-ping Xiong, Martin J. Humphries i Harold A. Chapman. "Regulation of α5β1 integrin conformation and function by urokinase receptor binding". Journal of Cell Biology 168, nr 3 (31.01.2005): 501–11. http://dx.doi.org/10.1083/jcb.200404112.
Pełny tekst źródłaLi, Y., i P. J. Cozzi. "Targeting uPA/uPAR in prostate cancer". Cancer Treatment Reviews 33, nr 6 (październik 2007): 521–27. http://dx.doi.org/10.1016/j.ctrv.2007.06.003.
Pełny tekst źródłaSah, Dhiraj Kumar, Pham Ngoc Khoi, Shinan Li, Archana Arjunan, Jae-Uk Jeong i Young Do Jung. "(-)-Epigallocatechin-3-Gallate Prevents IL-1β-Induced uPAR Expression and Invasiveness via the Suppression of NF-κB and AP-1 in Human Bladder Cancer Cells". International Journal of Molecular Sciences 23, nr 22 (13.11.2022): 14008. http://dx.doi.org/10.3390/ijms232214008.
Pełny tekst źródłaUhrin, Pavel, i Johannes M. Breuss. "uPAR". Cell Adhesion & Migration 7, nr 1 (styczeń 2013): 23–26. http://dx.doi.org/10.4161/cam.22124.
Pełny tekst źródłaShang, Run-Ze. "Role of uPA/uPAR system in tumors". World Chinese Journal of Digestology 22, nr 9 (2014): 1235. http://dx.doi.org/10.11569/wcjd.v22.i9.1235.
Pełny tekst źródłaLippert, Solvej, Kasper Drimer Berg, Peter Iversen, Gunilla Høyer-Hansen, Ib Jarle Christensen, Klaus Brasso i M. Andreas Røder. "Urokinase plasminogen activator receptor (uPAR) as a novel biomarker in prostate cancer." Journal of Clinical Oncology 33, nr 7_suppl (1.03.2015): 183. http://dx.doi.org/10.1200/jco.2015.33.7_suppl.183.
Pełny tekst źródłaGorrasi, Anna, Anna Maria Petrone, Anna Li Santi, Mariaevelina Alfieri, Nunzia Montuori i Pia Ragno. "New Pieces in the Puzzle of uPAR Role in Cell Migration Mechanisms". Cells 9, nr 12 (24.11.2020): 2531. http://dx.doi.org/10.3390/cells9122531.
Pełny tekst źródłaPark, Young-Jun, Gang Liu, Yuko Tsuruta, Emmanuel Lorne i Edward Abraham. "Participation of the urokinase receptor in neutrophil efferocytosis". Blood 114, nr 4 (23.07.2009): 860–70. http://dx.doi.org/10.1182/blood-2008-12-193524.
Pełny tekst źródłaKotzsch, Matthias, Axel Meye, Thomaz Langerholc, Susanne Füssel, Natalie Olbricht, Sybille Albrecht, Detlev Ockert i in. "Identification of a novel urokinase receptor splice variant and its prognostic relevance in breast cancer". Thrombosis and Haemostasis 89, nr 04 (2003): 705–17. http://dx.doi.org/10.1055/s-0037-1613577.
Pełny tekst źródłaBreuss, Johannes M., i Pavel Uhrin. "VEGF-initiated angiogenesis and the uPA/uPAR system". Cell Adhesion & Migration 6, nr 6 (17.11.2012): 535–40. http://dx.doi.org/10.4161/cam.22243.
Pełny tekst źródłaYepes, Manuel. "The uPA/uPAR system in astrocytic wound healing". Neural Regeneration Research 17, nr 11 (2022): 2404. http://dx.doi.org/10.4103/1673-5374.338991.
Pełny tekst źródłaMondino, Anna, i Francesco Blasi. "uPA and uPAR in fibrinolysis, immunity and pathology". Trends in Immunology 25, nr 8 (sierpień 2004): 450–55. http://dx.doi.org/10.1016/j.it.2004.06.004.
Pełny tekst źródłaShetty, S., A. Kumar i S. Idell. "Posttranscriptional regulation of urokinase receptor mRNA: identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells." Molecular and Cellular Biology 17, nr 3 (marzec 1997): 1075–83. http://dx.doi.org/10.1128/mcb.17.3.1075.
Pełny tekst źródłaShetty, Sreerama, Thirunavukkarasu Velusamy, Steven Idell, Hua Tang i Praveen Kumar Shetty. "Regulation of urokinase receptor expression by protein tyrosine phosphatases". American Journal of Physiology-Lung Cellular and Molecular Physiology 292, nr 2 (luty 2007): L414—L421. http://dx.doi.org/10.1152/ajplung.00121.2006.
Pełny tekst źródłaAlfieri, Mariaevelina, Anna Li Santi, Luigia Meo, Valentina Giudice, Carmine Selleri i Pia Ragno. "Identification of uPAR Variants Acting as ceRNAs in Leukaemia Cells". Cancers 14, nr 8 (14.04.2022): 1980. http://dx.doi.org/10.3390/cancers14081980.
Pełny tekst źródłaMatsuno, Hiroyuki, Eri Kawashita, Kiyotaka Okada, Hidetaka Suga, Shigeru Ueshima, Osamu Matsuo i Yosuke Kanno. "Urokinase-type plasminogen activator receptor is associated with the development of adipose tissue". Thrombosis and Haemostasis 104, nr 12 (2010): 1124–32. http://dx.doi.org/10.1160/th10-02-0101.
Pełny tekst źródłaShetty, Sreerama, Thirunavukkarasu Velusamy, Steven Idell, Praveenkumar Shetty, Andrew P. Mazar, Yashodhar P. Bhandary i Rashmi S. Shetty. "Regulation of Urokinase Receptor Expression by p53: Novel Role in Stabilization of uPAR mRNA". Molecular and Cellular Biology 27, nr 16 (4.06.2007): 5607–18. http://dx.doi.org/10.1128/mcb.00080-07.
Pełny tekst źródłaPrager, Gerald, Rene Novotny, Matthias Unseld, Marina Poettler, Waclawa Kalinowska, Johannes Breuss i Christoph Zielinski. "Urokinase-Type Plasminogen Activator Receptor (uPAR, CD87) Regulates Integrin Redistribution in Endothelial Cells Via Interaction with Low Density Lipoprotein Receptor- (LDLR-) Like Proteins". Blood 118, nr 21 (18.11.2011): 5315. http://dx.doi.org/10.1182/blood.v118.21.5315.5315.
Pełny tekst źródłaPiironen, Timo, Birgitte Laursen, Jesper Pass, Karin List, Henrik Gårdsvoll, Michael Ploug, Keld Danø i Gunilla Høyer-Hansen. "Specific Immunoassays for Detection of Intact and Cleaved Forms of the Urokinase Receptor". Clinical Chemistry 50, nr 11 (1.11.2004): 2059–68. http://dx.doi.org/10.1373/clinchem.2004.038232.
Pełny tekst źródłaPiironen, Timo, Alexander Haese, Hartwig Huland, Thomas Steuber, Ib Jarle Christensen, Nils Brünner, Keld Danø, Gunilla Høyer-Hansen i Hans Lilja. "Enhanced Discrimination of Benign from Malignant Prostatic Disease by Selective Measurements of Cleaved Forms of Urokinase Receptor in Serum". Clinical Chemistry 52, nr 5 (1.05.2006): 838–44. http://dx.doi.org/10.1373/clinchem.2005.064253.
Pełny tekst źródłaMihaly, Judit, Gerald Prager i Bernd Binder. "uPAR – uPA – PAI-1 interactions and signaling: A vascular biologist’s view". Thrombosis and Haemostasis 97, nr 03 (2007): 336–42. http://dx.doi.org/10.1160/th06-11-0669.
Pełny tekst źródłaDekkers, Pascale E. P., Tessa ten Hove, Anje A. te Velde, Sander J. H. van Deventer i Tom van der Poll. "Upregulation of Monocyte Urokinase Plasminogen Activator Receptor during Human Endotoxemia". Infection and Immunity 68, nr 4 (1.04.2000): 2156–60. http://dx.doi.org/10.1128/iai.68.4.2156-2160.2000.
Pełny tekst źródłaMazzieri, Roberta, Silvia D'Alessio, Richard Kamgang Kenmoe, Liliana Ossowski i Francesco Blasi. "An Uncleavable uPAR Mutant Allows Dissection of Signaling Pathways in uPA-dependent Cell Migration". Molecular Biology of the Cell 17, nr 1 (styczeń 2006): 367–78. http://dx.doi.org/10.1091/mbc.e05-07-0635.
Pełny tekst źródłaTincknell, Gary, Ann-Katrin Piper, Morteza Aghmesheh, Therese Becker, Kara Lea Vine, Daniel Brungs i Marie Ranson. "Experimental and Clinical Evidence Supports the Use of Urokinase Plasminogen Activation System Components as Clinically Relevant Biomarkers in Gastroesophageal Adenocarcinoma". Cancers 13, nr 16 (14.08.2021): 4097. http://dx.doi.org/10.3390/cancers13164097.
Pełny tekst źródłaShetty, Sreerama, i Steven Idell. "A urokinase receptor mRNA binding protein from rabbit lung fibroblasts and mesothelial cells". American Journal of Physiology-Lung Cellular and Molecular Physiology 274, nr 6 (1.06.1998): L871—L882. http://dx.doi.org/10.1152/ajplung.1998.274.6.l871.
Pełny tekst źródłaTjwa, Marc, Lieve Moons, Koen Theunissen, Rute Moura, Francesco Blasi, Mieke Dewerchin, Nicolai Sidenius, Desire Collen i Peter Carmeliet. "Role of Plasmin and uPAR in Bone Marrow HSC/HPC Retention and Mobilization." Blood 106, nr 11 (16.11.2005): 472. http://dx.doi.org/10.1182/blood.v106.11.472.472.
Pełny tekst źródłaCzekay, Ralf-Peter, Thomas A. Kuemmel, Robert A. Orlando i Marilyn Gist Farquhar. "Direct Binding of Occupied Urokinase Receptor (uPAR) to LDL Receptor-related Protein Is Required for Endocytosis of uPAR and Regulation of Cell Surface Urokinase Activity". Molecular Biology of the Cell 12, nr 5 (maj 2001): 1467–79. http://dx.doi.org/10.1091/mbc.12.5.1467.
Pełny tekst źródłaMekkawy, Ahmed H., David L. Morris i Mohammad H. Pourgholami. "HAX1 Augments Cell Proliferation, Migration, Adhesion, and Invasion Induced by Urokinase-Type Plasminogen Activator Receptor". Journal of Oncology 2012 (2012): 1–9. http://dx.doi.org/10.1155/2012/950749.
Pełny tekst źródłaMekkawy, Ahmed H., i David L. Morris. "Human Sprouty1 Suppresses Urokinase Receptor-Stimulated Cell Migration and Invasion". ISRN Biochemistry 2013 (12.09.2013): 1–7. http://dx.doi.org/10.1155/2013/598251.
Pełny tekst źródłaKumar, Ashna A., Benjamin J. Buckley i Marie Ranson. "The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets". Biomolecules 12, nr 2 (18.01.2022): 152. http://dx.doi.org/10.3390/biom12020152.
Pełny tekst źródłaGhiso, Julio A. Aguirre, Katherine Kovalski i Liliana Ossowski. "Tumor Dormancy Induced by Downregulation of Urokinase Receptor in Human Carcinoma Involves Integrin and MAPK Signaling". Journal of Cell Biology 147, nr 1 (4.10.1999): 89–104. http://dx.doi.org/10.1083/jcb.147.1.89.
Pełny tekst źródłaMagdolen, V., M. Bürgle, H. Kessler, S. Creutzburg, D. Helmecke, U. Reuning, H. Graeff, O. Wilhelm i M. Scmitt. "184 Inhibition of uPA/uPAR-interaction by cyclic uPA-derived peptides". Fibrinolysis and Proteolysis 11 (październik 1997): 53. http://dx.doi.org/10.1016/s0268-9499(97)80299-8.
Pełny tekst źródłaShetty, Sreerama, Malathesha Ganachari, Ming-Cheh Liu, Ali Azghani, Harish Muniyappa i Steven Idell. "Regulation of urokinase receptor expression by phosphoglycerate kinase is independent of its catalytic activity". American Journal of Physiology-Lung Cellular and Molecular Physiology 289, nr 4 (październik 2005): L591—L598. http://dx.doi.org/10.1152/ajplung.00319.2004.
Pełny tekst źródłaBernstein, Audrey M., Sally S. Twining, Debra J. Warejcka, Edward Tall i Sandra K. Masur. "Urokinase Receptor Cleavage: A Crucial Step in Fibroblast-to-Myofibroblast Differentiation". Molecular Biology of the Cell 18, nr 7 (lipiec 2007): 2716–27. http://dx.doi.org/10.1091/mbc.e06-10-0912.
Pełny tekst źródłaSmaradhania, Nilam, Septiman Rahman, Salman Ardi Syamsu i Prihantono Prihantono. "Urokinase type plasminogen activator receptor (uPAR) and human epidermal growth factor receptor 2 (HER2) expression in metastasis of breast cancer". Breast Disease 40 (25.06.2021): S1—S7. http://dx.doi.org/10.3233/bd-219001.
Pełny tekst źródłaBass, Rosemary, i Vincent Ellis. "Regulation of urokinase receptor function and pericellular proteolysis by the integrin α5β1". Thrombosis and Haemostasis 101, nr 05 (2009): 954–62. http://dx.doi.org/10.1160/th08-08-0558.
Pełny tekst źródłaThurison, Tine, Anne F. Lomholt, Morten G. Rasch, Ida K. Lund, Hans J. Nielsen, Ib J. Christensen i Gunilla Høyer-Hansen. "A New Assay for Measurement of the Liberated Domain I of the Urokinase Receptor in Plasma Improves the Prediction of Survival in Colorectal Cancer". Clinical Chemistry 56, nr 10 (1.10.2010): 1636–40. http://dx.doi.org/10.1373/clinchem.2010.144410.
Pełny tekst źródłaShmakova, Anna A., Polina S. Klimovich, Karina D. Rysenkova, Vladimir S. Popov, Anna S. Gorbunova, Anna A. Karpukhina, Maxim N. Karagyaur, Kseniya A. Rubina, Vsevolod A. Tkachuk i Ekaterina V. Semina. "Urokinase Receptor uPAR Downregulation in Neuroblastoma Leads to Dormancy, Chemoresistance and Metastasis". Cancers 14, nr 4 (16.02.2022): 994. http://dx.doi.org/10.3390/cancers14040994.
Pełny tekst źródłaRinaldi, Loredana, Vincenza Elena Anna Rea, Nunzia Montuori, Vincenzo Cosimato, Daniela Alfano i Pia Ragno. "uPAR regulates pericellular proteolysis through a mechanism involving integrins and fMLF-receptors". Thrombosis and Haemostasis 109, nr 02 (2013): 309–18. http://dx.doi.org/10.1160/th12-08-0546.
Pełny tekst źródłaSitrin, Robert G., Pauline M. Pan, Hollie A. Harper, R. Alexander Blackwood i Robert F. Todd. "Urokinase Receptor (CD87) Aggregation Triggers Phosphoinositide Hydrolysis and Intracellular Calcium Mobilization in Mononuclear Phagocytes". Journal of Immunology 163, nr 11 (1.12.1999): 6193–200. http://dx.doi.org/10.4049/jimmunol.163.11.6193.
Pełny tekst źródłaUnseld, Matthias, Anastasia Chilla, Clemens Pausz, Rula Mawas, Johannes Breuss, Christoph Zielinski, Gernot Schabbauer i Gerald Prager. "PTEN expression in endothelial cells is down-regulated by uPAR to promote angiogenesis". Thrombosis and Haemostasis 114, nr 08 (2015): 379–89. http://dx.doi.org/10.1160/th15-01-0016.
Pełny tekst źródłaPulukuri, Sai MuraliKrishna, Christopher S. Gondi, Sajani S. Lakka, Aman Jutla, Norman Estes, Meena Gujrati i Jasti S. Rao. "RNA Interference-directed Knockdown of Urokinase Plasminogen Activator and Urokinase Plasminogen Activator Receptor Inhibits Prostate Cancer Cell Invasion, Survival, and Tumorigenicity in Vivo". Journal of Biological Chemistry 280, nr 43 (26.08.2005): 36529–40. http://dx.doi.org/10.1074/jbc.m503111200.
Pełny tekst źródłaJardi, Mercè, Julia Inglés-Esteve, Maria Burgal, Carmen Azqueta, Francisco Velasco, Chary López-Pedrera, Lindsey Miles i Jordi Félez. "Distinct Patterns of Urokinase Receptor (uPAR) Expression by Leukemic Cells and Peripheral Blood Cells". Thrombosis and Haemostasis 76, nr 06 (1996): 1009–19. http://dx.doi.org/10.1055/s-0038-1650701.
Pełny tekst źródłaChi Ki Ngo, Jacky, Longguang Jiang, Zhonghui Lin, Cai Yuan, Zhuo Chen, Xu Zhang, Haiyang Yu, Jundong Wang, Lin Lin i Mingdong Huang. "Structural Basis for Therapeutic Intervention of uPA/uPAR System". Current Drug Targets 12, nr 12 (1.11.2011): 1729–43. http://dx.doi.org/10.2174/138945011797635911.
Pełny tekst źródłaDass, Kathleen, Aamir Ahmad, Asfar S. Azmi, Sarah H. Sarkar i Fazlul H. Sarkar. "Evolving role of uPA/uPAR system in human cancers". Cancer Treatment Reviews 34, nr 2 (kwiecień 2008): 122–36. http://dx.doi.org/10.1016/j.ctrv.2007.10.005.
Pełny tekst źródłaWoodman, Isabel. "uPA–uPAR at the heart of cardiac neonatal lupus". Nature Reviews Rheumatology 9, nr 6 (7.05.2013): 322. http://dx.doi.org/10.1038/nrrheum.2013.70.
Pełny tekst źródłaWei, Ying, Johannes A. Eble, Zemin Wang, Jordan A. Kreidberg i Harold A. Chapman. "Urokinase Receptors Promote β1 Integrin Function through Interactions with Integrin α3β1". Molecular Biology of the Cell 12, nr 10 (październik 2001): 2975–86. http://dx.doi.org/10.1091/mbc.12.10.2975.
Pełny tekst źródłaConnolly, Brian M., Eun Young Choi, Henrik Gårdsvoll, Alexandra L. Bey, Brooke M. Currie, Triantafyllos Chavakis, Shihui Liu i in. "Selective abrogation of the uPA-uPAR interaction in vivo reveals a novel role in suppression of fibrin-associated inflammation". Blood 116, nr 9 (2.09.2010): 1593–603. http://dx.doi.org/10.1182/blood-2010-03-276642.
Pełny tekst źródłaHau, Andrew M., Andrew Gilder, Jing-jing Hu, Steven L. Gonias i Donna E. Hansel. "uPAR and mTORC2 as coupled targets for therapeutics development in bladder cancer." Journal of Clinical Oncology 34, nr 2_suppl (10.01.2016): 447. http://dx.doi.org/10.1200/jco.2016.34.2_suppl.447.
Pełny tekst źródła